Tuberculosis control, and the where and why of artificial intelligence

Riddhi Doshi, Dennis Falzon, Bruce V. Thomas, Zelalem Temesgen, Lal Sadasivan, Giovanni Battista Migliori, Mario Raviglione

Source: ERJ Open Res, 3 (2) 00056-2017; 10.1183/23120541.00056-2017
Journal Issue: April
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Riddhi Doshi, Dennis Falzon, Bruce V. Thomas, Zelalem Temesgen, Lal Sadasivan, Giovanni Battista Migliori, Mario Raviglione. Tuberculosis control, and the where and why of artificial intelligence. ERJ Open Res, 3 (2) 00056-2017; 10.1183/23120541.00056-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tuberculosis control strategy modelling
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009

Artificial neural network (ANN) for prediction of pulmonary tuberculosis in hospitalized patients
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013


Chance acquaintanceship with long-term consequences
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Tuberculosis control in Europe
Source: Eur Respir J 2001; 18: Suppl. 33, 144s
Year: 2001

Home based tuberculosis (TB) care program
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Tuberculosis control in Europe - current situation
Source: Annual Congress 2003 - Tuberculosis control in Europe - current situation
Year: 2003

Modern social and clinical characteristics of miliary tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Tuberculosis (TB) and depression
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013

Joint WHO/ERS initiative on e-/m-Health for TB and tobacco control
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Tuberculosis in native and foreign born populations in Portugal
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Gender differences in active tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Tuberculosis (TB) and young age
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Predictive factors of a delayed culture conversion under tuberculosis treatment
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013


Evaluation of a tuberculosis control programme based on case-finding
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Use of artificial intelligence for improving quality control of oscillometry
Source: Virtual Congress 2021 – Impact of COVID - 19, quality assurance and technology on pulmonary function
Year: 2021



Is it necessary to give tuberculosis treatment daily throughout?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Tuberculosis in London: the convergence of clinical and social complexity
Source: Eur Respir J 2016; 48: 1233-1236
Year: 2016


Tuberculosis (TB) in homeless population in Poland
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Properties of cultures of M. tuberculosis isolated from the surfaces of objects TB facilities
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013


Using results of new laboratory test for tuberculosis infection in children
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013